Research challenges in central nervous system manifestations of inborn errors of metabolism

P. I. Dickson; A. R. Pariser; S. C. Groft; R. W. Ishihara; D. E. McNeil; D. Tagle; D. J. Griebel; S. G. Kaler; J. W. Mink; E. G. Shapiro; K. J. Bjoraker; L. Krivitzky; J. M. Provenzale; A. Gropman; P. Orchard; G. Raymond; B. H. Cohen; R. D. Steiner; S. F. Goldkind; R. M. Nelson; E. Kakkis; M. C. Patterson

doi:10.1016/j.ymgme.2010.11.164

Research challenges in central nervous system manifestations of inborn errors of metabolism

P. I. Dickson, A. R. Pariser, S. C. Groft, R. W. Ishihara, D. E. McNeil, D. Tagle, D. J. Griebel, S. G. Kaler, J. W. Mink, E. G. Shapiro, K. J. Bjoraker, L. Krivitzky, J. M. Provenzale, A. Gropman, P. Orchard, G. Raymond, B. H. Cohen, R. D. Steiner, S. F. Goldkind, R. M. NelsonE. Kakkis, M. C. Patterson

Neurology

Research output: Contribution to journal › Review article

15 Scopus citations

Abstract

The Research Challenges in CNS Manifestations of Inborn Errors of Metabolism workshop was designed to address challenges in translating potential therapies for these rare disorders, and to highlight novel therapeutic strategies and innovative approaches to CNS delivery, assessment of effects and directions for the future in the treatment of these diseases. Therapies for the brain in inborn errors represent some of the greatest challenges to translational research due to the special properties of the brain, and of inborn errors themselves. This review covers the proceedings of this workshop as submitted by participants. Scientific, ethical and regulatory issues are discussed, along with ways to measure outcomes and the conduct of clinical trials. Participants included regulatory and funding agencies, clinicians, scientists, industry and advocacy groups.

Original language	English (US)
Pages (from-to)	326-338
Number of pages	13
Journal	Molecular genetics and metabolism
Volume	102
Issue number	3
DOIs	https://doi.org/10.1016/j.ymgme.2010.11.164
State	Published - Mar 1 2011

Keywords

Central nervous system
Inborn errors of metabolism
Orphan drug designation
Rare disease
Translational research

ASJC Scopus subject areas

Endocrinology, Diabetes and Metabolism
Biochemistry
Molecular Biology
Genetics
Endocrinology

Access to Document

10.1016/j.ymgme.2010.11.164

Fingerprint Dive into the research topics of 'Research challenges in central nervous system manifestations of inborn errors of metabolism'. Together they form a unique fingerprint.

Cite this

Dickson, P. I., Pariser, A. R., Groft, S. C., Ishihara, R. W., McNeil, D. E., Tagle, D., Griebel, D. J., Kaler, S. G., Mink, J. W., Shapiro, E. G., Bjoraker, K. J., Krivitzky, L., Provenzale, J. M., Gropman, A., Orchard, P., Raymond, G., Cohen, B. H., Steiner, R. D., Goldkind, S. F., ... Patterson, M. C. (2011). Research challenges in central nervous system manifestations of inborn errors of metabolism. Molecular genetics and metabolism, 102(3), 326-338. https://doi.org/10.1016/j.ymgme.2010.11.164

Research challenges in central nervous system manifestations of inborn errors of metabolism. / Dickson, P. I.; Pariser, A. R.; Groft, S. C.; Ishihara, R. W.; McNeil, D. E.; Tagle, D.; Griebel, D. J.; Kaler, S. G.; Mink, J. W.; Shapiro, E. G.; Bjoraker, K. J.; Krivitzky, L.; Provenzale, J. M.; Gropman, A.; Orchard, P.; Raymond, G.; Cohen, B. H.; Steiner, R. D.; Goldkind, S. F.; Nelson, R. M.; Kakkis, E.; Patterson, M. C.

In: Molecular genetics and metabolism, Vol. 102, No. 3, 01.03.2011, p. 326-338.

Research output: Contribution to journal › Review article

Dickson, PI, Pariser, AR, Groft, SC, Ishihara, RW, McNeil, DE, Tagle, D, Griebel, DJ, Kaler, SG, Mink, JW, Shapiro, EG, Bjoraker, KJ, Krivitzky, L, Provenzale, JM, Gropman, A, Orchard, P, Raymond, G, Cohen, BH, Steiner, RD, Goldkind, SF, Nelson, RM, Kakkis, E & Patterson, MC 2011, 'Research challenges in central nervous system manifestations of inborn errors of metabolism', Molecular genetics and metabolism, vol. 102, no. 3, pp. 326-338. https://doi.org/10.1016/j.ymgme.2010.11.164

Dickson, P. I. ; Pariser, A. R. ; Groft, S. C. ; Ishihara, R. W. ; McNeil, D. E. ; Tagle, D. ; Griebel, D. J. ; Kaler, S. G. ; Mink, J. W. ; Shapiro, E. G. ; Bjoraker, K. J. ; Krivitzky, L. ; Provenzale, J. M. ; Gropman, A. ; Orchard, P. ; Raymond, G. ; Cohen, B. H. ; Steiner, R. D. ; Goldkind, S. F. ; Nelson, R. M. ; Kakkis, E. ; Patterson, M. C. / Research challenges in central nervous system manifestations of inborn errors of metabolism. In: Molecular genetics and metabolism. 2011 ; Vol. 102, No. 3. pp. 326-338.

@article{c05a7f74d2aa43f5a5f18a87fd899f68,

title = "Research challenges in central nervous system manifestations of inborn errors of metabolism",

abstract = "The Research Challenges in CNS Manifestations of Inborn Errors of Metabolism workshop was designed to address challenges in translating potential therapies for these rare disorders, and to highlight novel therapeutic strategies and innovative approaches to CNS delivery, assessment of effects and directions for the future in the treatment of these diseases. Therapies for the brain in inborn errors represent some of the greatest challenges to translational research due to the special properties of the brain, and of inborn errors themselves. This review covers the proceedings of this workshop as submitted by participants. Scientific, ethical and regulatory issues are discussed, along with ways to measure outcomes and the conduct of clinical trials. Participants included regulatory and funding agencies, clinicians, scientists, industry and advocacy groups.",

keywords = "Central nervous system, Inborn errors of metabolism, Orphan drug designation, Rare disease, Translational research",

author = "Dickson, {P. I.} and Pariser, {A. R.} and Groft, {S. C.} and Ishihara, {R. W.} and McNeil, {D. E.} and D. Tagle and Griebel, {D. J.} and Kaler, {S. G.} and Mink, {J. W.} and Shapiro, {E. G.} and Bjoraker, {K. J.} and L. Krivitzky and Provenzale, {J. M.} and A. Gropman and P. Orchard and G. Raymond and Cohen, {B. H.} and Steiner, {R. D.} and Goldkind, {S. F.} and Nelson, {R. M.} and E. Kakkis and Patterson, {M. C.}",

year = "2011",

month = mar,

day = "1",

doi = "10.1016/j.ymgme.2010.11.164",

language = "English (US)",

volume = "102",

pages = "326--338",

journal = "Molecular Genetics and Metabolism",

issn = "1096-7192",

publisher = "Academic Press Inc.",

number = "3",

}

TY - JOUR

T1 - Research challenges in central nervous system manifestations of inborn errors of metabolism

AU - Dickson, P. I.

AU - Pariser, A. R.

AU - Groft, S. C.

AU - Ishihara, R. W.

AU - McNeil, D. E.

AU - Tagle, D.

AU - Griebel, D. J.

AU - Kaler, S. G.

AU - Mink, J. W.

AU - Shapiro, E. G.

AU - Bjoraker, K. J.

AU - Krivitzky, L.

AU - Provenzale, J. M.

AU - Gropman, A.

AU - Orchard, P.

AU - Raymond, G.

AU - Cohen, B. H.

AU - Steiner, R. D.

AU - Goldkind, S. F.

AU - Nelson, R. M.

AU - Kakkis, E.

AU - Patterson, M. C.

PY - 2011/3/1

Y1 - 2011/3/1

N2 - The Research Challenges in CNS Manifestations of Inborn Errors of Metabolism workshop was designed to address challenges in translating potential therapies for these rare disorders, and to highlight novel therapeutic strategies and innovative approaches to CNS delivery, assessment of effects and directions for the future in the treatment of these diseases. Therapies for the brain in inborn errors represent some of the greatest challenges to translational research due to the special properties of the brain, and of inborn errors themselves. This review covers the proceedings of this workshop as submitted by participants. Scientific, ethical and regulatory issues are discussed, along with ways to measure outcomes and the conduct of clinical trials. Participants included regulatory and funding agencies, clinicians, scientists, industry and advocacy groups.

AB - The Research Challenges in CNS Manifestations of Inborn Errors of Metabolism workshop was designed to address challenges in translating potential therapies for these rare disorders, and to highlight novel therapeutic strategies and innovative approaches to CNS delivery, assessment of effects and directions for the future in the treatment of these diseases. Therapies for the brain in inborn errors represent some of the greatest challenges to translational research due to the special properties of the brain, and of inborn errors themselves. This review covers the proceedings of this workshop as submitted by participants. Scientific, ethical and regulatory issues are discussed, along with ways to measure outcomes and the conduct of clinical trials. Participants included regulatory and funding agencies, clinicians, scientists, industry and advocacy groups.

KW - Central nervous system

KW - Inborn errors of metabolism

KW - Orphan drug designation

KW - Rare disease

KW - Translational research

UR - http://www.scopus.com/inward/record.url?scp=79851510629&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79851510629&partnerID=8YFLogxK

U2 - 10.1016/j.ymgme.2010.11.164

DO - 10.1016/j.ymgme.2010.11.164

M3 - Review article

C2 - 21176882

AN - SCOPUS:79851510629

VL - 102

SP - 326

EP - 338

JO - Molecular Genetics and Metabolism

JF - Molecular Genetics and Metabolism

SN - 1096-7192

IS - 3

ER -